Delivery Order SPE2DB24D9131-SPE2DB24FXRR3

Award Date 9/3/24
Potential Completion Date 9/24/24
Potential Value $69K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $72,628.98 firm fixed-price delivery order is for the supply of UPTRAVI 800 MCG TABLET 60S, a prescription medication. The contract has an ultimate completion date of July 15, 2025. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
This is a federal contract award by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $36,297.66 firm fixed-price delivery order contract is for the supply of the prescription drug UPTRAVI 1,600 MCG TABLET 60S. The contract has a period of performance through June 4, 2025 and is not set aside for any specific business category. DMS Pharmaceutical Group Inc. holds a larger $499,999,999...
This federal contract award, valued at $75,556.44, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order for UPTRAVI 800 MCG TABLET 60S, a specialized pharmaceutical product. DMS Pharmaceutical Group holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through...
This federal contract award, valued at $75,379.08, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of UPTRAVI 800 MCG TABLET 60S, a specialized pharmaceutical product. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at...
The federal contract award is to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, awarded by the Defense Logistics Agency (DLA), is a delivery order under the DLA's SPE2DB program, a single-award indefinite delivery contract (IDC) valued at up to $499,999,999 and running through December 31, 2025. This order, with a ceiling value of $69,320.52, is for the delivery of the pharmaceutical product UPTRAVI 800 MCG...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $66,359.82 contract is for the delivery of the medication UPTRAVI 800 MCG tablets. The delivery order has a completion date of March 28, 2024. DMS Pharmaceutical Group holds a broader indefinite delivery contract with DLA, valued at up to $4,999,999, to provide a range of...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business based in Park Ridge, Illinois. The $66,328.98 contract is for the delivery of UPTRAVI 1,600 MCG tablets to support U.S. government medical requirements. DMS Pharmaceutical Group holds a larger indefinite delivery contract, valued up to $4,999,999, with the Defense Logistics Agency for a broad range of pharmaceutical products to meet the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $34,644.18 firm fixed-price contract is for the supply of Uptravi 1,600 mcg tablets to support the medical needs of the U.S. Department of Defense (DoD) and its health facilities. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999,...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide the pharmaceutical item UPTRAVI 800 MCG TABLET 60S. The contract has a potential value of $108,558.99 and a period of performance through June 27, 2023. DMS Pharmaceutical Group Inc. is an experienced federal contractor that holds multiple indefinite delivery contracts with DLA to supply a wide range of prescription...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $75,379.08, is for the delivery of 60 count bottles of the prescription drug Uptravi 800 mcg tablets. This award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which covers...
  • SPE2DB24D9131
    Indefinite Delivery Contract
  • SPE2DB24D9131-SPE2DB24FXRR3
    Delivery Order

This contract award is for the delivery of UPTRAVI 800 MCG TABLET 60S to the Defense Logistics Agency (DLA), a defense agency. The award, valued at $69,320.52, was made to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order with no set-aside designation, running through September 24, 2024.

DMS Pharmaceutical Group Inc. holds a $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to support the recurring medical supply needs of military health facilities worldwide. This award is likely one such delivery order issued under that larger IDC vehicle, solidifying DMS Pharmaceutical Group's position as a crucial supplier in the federal pharmaceutical supply chain.

Generated 12/3/24, 9:57 AM